https://www.selleckchem.com/pr....oducts/Fulvestrant.h
Notably, patients with psoriatic disease had a higher OR of developing bone fractures (adjusted OR 1.09; 95% CI 1.06 to 1.12; I 0%). Patients with psoriatic disease may be more likely to develop fractures compared with non-psoriatic controls. This higher risk for fracture may not necessarily be associated with lower bone mineral density nor a higher risk for osteoporosis. Patients with psoriatic disease may be more likely to develop fractures compared with non-psoriatic controls. This higher risk for fracture may not necessarily be
Curtir
Comentario
Compartilhar
